Filtered By:
Procedure: Hemodialysis
Vaccination: Vaccines
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 315 results found since Jan 2013.
New Onset Biopsy-Proven Nephropathies after COVID Vaccination
This study aimed to examine the patients who were hospitalized in our Unit between April and November 2021 and underwent renal biopsy for new-onset urinary abnormalities (UA) and/or renal impairment within 3 months of SARS-CoV-2 vaccination.RESULTS: We identified 17 patients who developed UA and/or renal insufficiency within 3 months of vaccination. Minimal change disease was the most common disease in our cohort (5 patients, 29.4%) followed by acute tubulointerstitial nephritis (TIN; 3 patients, 17.6%), membranous nephropathy (3 patients, 17.6%), and rapidly progressive IgA nephropathy (2 patients, 11.8%). The other 4 pat...
Source: American Journal of Nephrology - March 30, 2022 Category: Urology & Nephrology Authors: Roberta Fenoglio Stefania Lalloni Martina Marchisio Valentina Oddone Emanuele De Simone Giulio Del Vecchio Savino Sciascia Dario Roccatello Source Type: research
A Case Report of Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination and Heparin Use During Hemodialysis
J Korean Med Sci. 2022 Mar 14;37(10):e75. doi: 10.3346/jkms.2022.37.e75.ABSTRACTVaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but life-threatening complication. VITT strongly mimics heparin-induced thrombocytopenia (HIT) and shares clinical features. Heparin is commonly used to prevent coagulation during hemodialysis. Therefore, nephrologists might encounter patients needing dialysis with a history of heparin exposure who developed thrombotic thrombocytopenia after vaccination. A 70-year-old male presented with acute kidney injury and altered mental status due to lithium intoxication. He needed consec...
Source: J Korean Med Sci - March 15, 2022 Category: General Medicine Authors: Young-Bin Son Tae-Bum Kim Hyeon-Jin Min Jonghyun Lee Jihyun Yang Myung-Gyu Kim Sang Kyung Jo Won Yong Cho Se Won Oh Source Type: research
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination
Emerg Infect Dis. 2022 Feb 24;28(4). doi: 10.3201/eid2804.211907. Online ahead of print.ABSTRACTPatients undergoing chronic hemodialysis were among the first to receive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations because of their increased risk for severe coronavirus disease and high case-fatality rates. By using a previously reported cohort from Germany of at-risk hemodialysis patients and healthy donors, where antibody responses were examined 3 weeks after the second vaccination, we assessed systemic cellular and humoral immune responses in serum and saliva 4 months after vaccination with th...
Source: Emerging Infectious Diseases - February 24, 2022 Category: Infectious Diseases Authors: Alex Dulovic Monika Strengert Gema Morillas Ramos Matthias Becker Johanna Griesbaum Daniel Junker Karsten L ürken Andrea Beigel Eike Wrenger Gerhard Lonnemann Anne Cossmann Metodi V Stankov Alexandra Dopfer-Jablonka Philipp D Kaiser Bjoern Traenkle Ulric Source Type: research
Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
J Nephrol. 2022 Feb 22:1-3. doi: 10.1007/s40620-022-01276-2. Online ahead of print.NO ABSTRACTPMID:35192157 | PMC:PMC8861617 | DOI:10.1007/s40620-022-01276-2
Source: Journal of Nephrology - February 22, 2022 Category: Urology & Nephrology Authors: Pierre Housset Sabah Kubab Agathe Pardon Nathalie Vittoz Dogan-Firat Bozman Latifa Hanafi Val érie Caudwell Anne-Laure Faucon Source Type: research
Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients
CONCLUSIONS: The study highlights the need for booster doses in KTRs. In contrast, the haemodialysis population appears to have an adequate clinical response to vaccination, at least up to four months from its administration.PMID:35191008 | PMC:PMC8860282 | DOI:10.1007/s40620-022-01257-5
Source: Journal of Nephrology - February 22, 2022 Category: Urology & Nephrology Authors: Diana Rodr íguez-Espinosa Enrique Montagud-Marrahi Judit Cacho Carolt Arana Natalia Taurizano Evelyn Hermida Jimena Del Risco-Zevallos Joaquim Casals Anney Rosario Elena Cuadrado-Pay án Alicia Molina-And újar N éstor Rodríguez Anna Vilella Marta Bodr Source Type: research
Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients
CONCLUSIONS: Breakthrough COVID-19 with the B.1.617.2 variant can occur in vaccinated hemodialysis patients and is associated with immunosuppression and weaker humoral response to vaccination. Infections may be nosocomial and result in significant morbidity and mortality.PMID:35175577 | DOI:10.1007/s40620-022-01245-9
Source: Journal of Nephrology - February 17, 2022 Category: Urology & Nephrology Authors: Ori Wand Naomi Nacasch Ayman Fadeela Moshe Shashar Ayelet Grupper Sydney Benchetrit Daniel Erez Pnina Shitrit Keren Cohen-Hagai Source Type: research
